The combination of tiraspatide and hormone therapy is associated with weight loss in postmenopausal women

(MedPage Today) – Orlando – Postmenopausal women using hormone therapy (HT) experienced significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist terzebatide than their non-HT counterparts, according to a retrospective study.